David E. Thurston
Impact in
- Organic Chemistry top 0.5%
- Synthesis and pharmacology of benzodiazepine derivatives
- Synthesis and Biological Evaluation
- Oncology top 1%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
-
- Synthesis and pharmacology of benzodiazepine derivatives 115
- Synthesis and Biological Evaluation 15
-
- Cancer therapeutics and mechanisms 101
- DNA and Nucleic Acid Chemistry 14
- Co-authors
- Philip W. Howard (47 shared papers)Khondaker Miraz Rahman (48 shared papers)Terence C. Jenkins (31 shared papers)D. Subhas Bose (8 shared papers)John A. Hartley (31 shared papers)Stephen Neidle (13 shared papers)Giovanna Zinzalla (8 shared papers)Dyeison Antonow (10 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (24 papers)Cancer Research (13 papers)Journal of Medicinal Chemistry (12 papers)Chemical Communications (9 papers)Tetrahedron Letters (7 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
David E. Thurston
173 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 125
- Organic Chemistry 3.4k
- Oncology 1.9k
- Molecular Biology 3.3k
- Infectious Diseases 494
- Toxicology 89
Countries citing papers authored by David E. Thurston
This map shows the geographic impact of David E. Thurston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Thurston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Thurston more than expected).
Fields of papers citing papers by David E. Thurston
This network shows the impact of papers produced by David E. Thurston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Thurston. The network helps show where David E. Thurston may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Thurston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 246 | |
| 2 | 2009 | 195 | |
| 3 | 2005 | 193 | |
| 4 | 2016 | 187 | |
| 5 | 2001 | 178 | |
| 6 | 2010 | 174 | |
| 7 | 2017 | 138 | |
| 8 | 1988 | 117 | |
| 9 | 2004 | 112 | |
| 10 | 1992 | 111 | |
| 11 | 2006 | 110 | |
| 12 | 1996 | 107 | |
| 13 | 2013 | 88 | |
| 14 | 1994 | 82 | |
| 15 | 1993 | 80 | |
| 16 | 1997 | 80 | |
| 17 | 2004 | 76 | |
| 18 | 1999 | 74 | |
| 19 | 1993 | 71 | |
| 20 | 2004 | 69 |
About David E. Thurston
David E. Thurston is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 177 papers that have together received 5.4k indexed citations. Recurring topics across this work include Synthesis and pharmacology of benzodiazepine derivatives (115 papers), Cancer therapeutics and mechanisms (101 papers), Cancer Treatment and Pharmacology (43 papers), HIV/AIDS drug development and treatment (19 papers), Synthesis and Biological Evaluation (15 papers), DNA and Nucleic Acid Chemistry (14 papers), HER2/EGFR in Cancer Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). The work is most often cited by research in Organic Chemistry (3.4k citations), Oncology (1.9k citations), Molecular Biology (3.3k citations), Infectious Diseases (494 citations) and Toxicology (89 citations). David E. Thurston has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Philip W. Howard, Khondaker Miraz Rahman, Terence C. Jenkins, D. Subhas Bose, John A. Hartley, Stephen Neidle, Giovanna Zinzalla, Dyeison Antonow, Paul J. Jackson and Laurence H. Hurley. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cancer Research, Journal of Medicinal Chemistry, Chemical Communications and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.